- A heart failure clinical trial is a research study testing whether a treatment — a drug, device, or procedure — is safe and effective; joining is voluntary, not guaranteed care.
- Trials run in phases 1 through 4, testing safety, effectiveness, comparison with standard care, and long-term monitoring after approval.
- You can search ClinicalTrials.gov by condition (such as HFrEF or HFpEF) and location, and ask your cardiologist which studies may fit.
- Informed consent means the team explains risks and benefits before you agree, and you may withdraw at any time without losing your regular care.
- Never stop a heart failure medication or skip a device therapy to qualify for a study without your cardiologist's guidance.
- Heart failure can worsen quickly; if you have severe breathlessness, chest pain, or fainting, seek urgent care rather than waiting on a trial.
A clinical trial for heart failure is a research study that tests whether a treatment — a medication, an implanted device, or a procedure — is safe and helps people whose hearts do not pump as well as they should. Taking part is voluntary, it is not the same as receiving proven treatment, and you can stop at any time. This guide explains what heart failure trials are, how the phases work, how to find one, and how to weigh the decision with your cardiologist. It is educational and does not replace medical advice.
Heart failure is common, and much of today’s standard care — the medications and devices that help people live longer and feel better — was proven in trials that volunteers made possible. Choosing to explore research is a reasonable, informed step for many patients, not a last resort or a sign that other options are gone.
One safety note first: heart failure can change quickly. If you have severe or sudden breathlessness, chest pain, fainting, or rapid weight gain from fluid, seek urgent medical care. A clinical trial is not a substitute for emergency treatment.
What a clinical trial actually is
As MedlinePlus and the NIH describe it, a clinical trial is a research study that tests how well a new medical approach works in people, guided by a written plan called a protocol. An Institutional Review Board (IRB) — clinicians, statisticians, and community members — reviews and monitors each study to protect participants and confirm that the possible benefits justify the risks. Many trials compare a new treatment against standard care or a placebo, and often use randomization, so a computer, not the researcher, assigns your group. For a fuller primer, see how clinical trials work.
The four phases, briefly
Trials run in phases, each asking a different question. This framework comes from the NIH.
| Phase | Main question | Typical size |
|---|---|---|
| Phase 1 | Is it safe? What dose is tolerable? | Small (roughly 20–80 people) |
| Phase 2 | Does it work, and is it still safe? | Larger (roughly 100–300) |
| Phase 3 | How does it compare with standard treatment? | Large (hundreds to thousands) |
| Phase 4 | How does it perform long-term after approval? | Ongoing, post-approval |
Heart failure research spans all four, and it includes more than drugs — studies also test devices, surgical approaches, and ways of delivering care. The NHLBI funds large heart failure research networks and long-term studies, including research focused on HFpEF (heart failure with preserved ejection fraction).
How to search for a heart failure trial
The main public database is ClinicalTrials.gov, run by the U.S. National Library of Medicine. Each study record shows recruitment status, eligibility criteria, locations, and contacts, plus a unique NCT number. To search:
- Enter a condition — “heart failure,” or a more specific term like “HFrEF” or “HFpEF” — and your city or state.
- Filter by recruitment status to see studies actively enrolling.
- Read the eligibility criteria, which often depend on your ejection fraction, symptoms, and other treatments.
- Use the listed contact to reach the study team with your questions.
Your cardiologist is also a good starting point — heart failure programs at academic medical centers frequently run trials and can tell you which ones fit your specific type and stage.
Informed consent and your right to withdraw
Before enrolling, the study team must walk you through informed consent: a process in which they explain the purpose, procedures, possible risks and benefits, and your alternatives. Take the form home, ask questions, and involve your cardiologist or a family member. Consent is not permanent — you have the right to withdraw at any time, for any reason, without penalty and without losing the standard care you would otherwise receive.
Research is not guaranteed treatment
A trial may test something that turns out not to help, and you may be placed in a comparison or placebo group. Enrolling does not guarantee improvement, and it should not replace proven heart failure care — the medications, devices, and lifestyle steps covered in our congestive heart failure guide. Treat a trial as one option to weigh alongside established treatment, not a shortcut around it.
Never change your current treatment on your own
Heart failure medications — and device therapies like an implanted defibrillator or pacemaker — are carefully balanced. Do not stop a medication, skip doses, or alter a device to qualify for a study. Abruptly stopping certain heart failure drugs can cause serious harm. If a trial requires a change, your cardiologist and the study team should coordinate it. The safe order is: explore eligibility first, change nothing until a clinician directs it.
Frequently asked questions
Is it safe to join a heart failure clinical trial?
Trials follow a protocol reviewed and monitored by an Institutional Review Board to protect participants, but no research is risk-free. The consent process explains the specific risks so you can decide. Review any trial with your cardiologist before agreeing.
Will I get a placebo instead of real treatment?
Some heart failure trials include a placebo or a comparison group, usually added on top of standard care rather than replacing it, and assignment is often random. The consent form states whether a placebo is possible — ask the study team to be sure.
Does it cost money to participate?
Study treatment is often provided at no cost and some trials cover travel, while other costs vary and may involve your insurance. Ask the study team exactly what is covered before you enroll.
Can I leave the study after I start?
Yes. You can withdraw at any time, for any reason, without penalty and without losing your usual medical care. Tell the study team so any study-specific treatment can be stopped safely.
Do I have to stop my heart medications to qualify?
Not on your own. Never stop or change a heart failure medication or device therapy to join a study without your cardiologist’s guidance, because abrupt changes can be dangerous. Let your clinician and the study team coordinate.
How do I find heart failure trials near me?
Search ClinicalTrials.gov by condition and location, filter for actively recruiting studies, and read the eligibility criteria. Ask your cardiologist or a nearby heart failure program, since many centers run their own trials.
This article is general education and is not medical advice. Talk to a qualified clinician about your situation.
Sources
- ClinicalTrials.gov — U.S. National Library of Medicine / National Institutes of Health (searching studies, phases, NCT numbers, eligibility)
- National Institutes of Health — “NIH Clinical Research Trials and You” (trial phases; informed consent)
- National Heart, Lung, and Blood Institute (NHLBI) — heart failure research networks and studies
- MedlinePlus, U.S. National Library of Medicine — Clinical Trials overview (protocol, IRB oversight)
Related reading: start with how clinical trials work, understand the condition in our congestive heart failure guide, compare research routes for clinical trials for other conditions, and browse the full Medical Conditions guide.